Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques

AIDS

Volumn 26, Issue 7, 2012, Pages 815-823

  Kelly, Kathleen M ^a,b   Tarwater, Patrick M ^c   Karper, Jami M ^a   Bedja, Djahida ^a   Queen, Suzanne E ^a   Tunin, Richard S ^b   Adams, Robert J ^a   Kass, David A ^b   Mankowski, Joseph L ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Paul L Foster School of Medicine   (United States)

Author keywords

cardiac; diastolic dysfunction; echocardiography; macrophages; myocardial viral load; simian immunodeficiency virus

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL POPULATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DETERIORATION; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; HEART MUSCLE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACACA; MACROPHAGE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIMIAN IMMUNODEFICIENCY VIRUS; TISSUE DOPPLER IMAGING; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER; HEART; MACACA; MACROPHAGES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 84859970831     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283518f01     Document Type: Article

References (53)

1. Herskowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr Opin Cardiol 1996; 11:325-331. (Pubitemid 26238080)
2. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, et al. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993; 71:955-958. (Pubitemid 23118068)
3. Hecht SR, Berger M, Van Tosh A, Croxson S. Unsuspected cardiac abnormalities in the acquired immune deficiency syndrome. An echocardiographic study. Chest 1989; 96:805-808. (Pubitemid 19256182)
4. Anderson DW, Virmani R, Reilly JM, O'Leary T, Cunnion RE, Robinowitz M, et al. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 1988; 11:792-799. (Pubitemid 18092188)
5. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol 1989; 13:1030-1036. (Pubitemid 19091290)
6. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Rocha Goncalves F, Lecour H. Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol 1998; 63:37-45. (Pubitemid 28060224)
7. Barbaro G, Barbarini G, Di Lorenzo G. Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: a multicenter echocardiographic and echo-Doppler study. The Gruppo Italiano Per lo Studio Cardiologico dei Pazienti Affetti da AIDS. AIDS Res Hum Retroviruses 1996; 12:1559-1563. (Pubitemid 26366915)
8. Longo-Mbenza B, Seghers LV, Vita EK, Tonduangu K, Bayekula M. Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study. Heart 1998; 80:184-189. (Pubitemid 28389482)
9. Mittal CM, Wig N, Mishra S, Arora P, Pandey RM. Cardiac dysfunction in human immunodeficiency virus (HIV) infected patients in India. Int J Cardiol 2006; 107:136-137. (Pubitemid 41767538)
10. Coudray N, de Zuttere D, Force G, Champetier de Ribes D, Pourny JC, Antony I, et al. Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 1995; 16:61-67.
11. Schuster I, Thoni GJ, Ederhy S, Walther G, Nottin S, Vinet A, et al. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol 2008; 101:1213-1217.
12. Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, et al. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail 2010; 3:132-139.
13. Martinez-Garcia T, Sobrino JM, Pujol E, Galvez J, Benitez E, Giron-Gonzalez JA. Ventricular mass and diastolic function in patients infected by the human immunodeficiency virus. Heart 2000; 84:620-624.
14. Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, et al. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials 2010; 11:156-162.
15. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000; 40:282-284. (Pubitemid 30447185)
16. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 2007; 5:129-137. (Pubitemid 46062366)
17. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 2007; 93:1176-1183. (Pubitemid 47492897)
18. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee S, et al. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 2002; 30:306-310. (Pubitemid 34774078)
19. Shannon RP. SIV cardiomyopathy in nonhuman primates. Trends Cardiovasc Med 2001; 11:242-246.
20. Shannon RP, Simon MA, Mathier MA, Geng YJ, Mankad S, Lackner AA. Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation 2000; 101:185-193. (Pubitemid 30044259)
21. Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak M Jr, Tarwater PM, et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002; 186:905-913.
22. Zink MC, Amedee AM, Mankowski JL, Craig L, Didier P, Carter DL, et al. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol 1997; 151:793-803. (Pubitemid 27385611)
23. Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M Jr, Spelman JP, et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999; 73:10480-10488.
24. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
25. Kass DA, Yamazaki T, Burkhoff D, Maughan WL, Sagawa K. Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation 1986; 73:586-595. (Pubitemid 16133038)
26. Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002; 61:85-90. (Pubitemid 34027723)
27. Witwer KW, Gama L, Li M, Bartizal CM, Queen SE, Varrone JJ, et al. Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One 2009; 4:e8129.
28. Schefe JH, Lehmann KE, Buschmann IR, Unger T, Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: current concepts and the novel 'gene expression's CT difference' formula. J Mol Med (Berl) 2006; 84:901-910. (Pubitemid 44655868)
29. Barbaro G. HIV-associated myocarditis. Heart Fail Clin 2005; 1:439-448.
30. Nakatsuji S, Yamate J, Kuwamura M, Kotani T, Sakuma S. In vivo responses of macrophages and myofibroblasts in the healing following isoproterenol-induced myocardial injury in rats. Virchows Arch 1997; 430:63-69. (Pubitemid 27073308)
31. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54:589-599. (Pubitemid 15132717)
32. Van den Berg TK, Dopp EA, Dijkstra CD. Rat macrophages: membrane glycoproteins in differentiation and function. Immunol Rev 2001; 184:45-57. (Pubitemid 34123763)
33. Liu QN, Reddy S, Sayre JW, Pop V, Graves MC, Fiala M. Essential role of HIV type 1-infected and cyclooxygenase 2-activated macrophages and T cells in HIV type 1 myocarditis. AIDS Res Hum Retroviruses 2001; 17:1423-1433. (Pubitemid 33042810)
34. Twu C, Liu NQ, Popik W, Bukrinsky M, Sayre J, Roberts J, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrionand death receptor-controlled pathways. Proc Natl Acad Sci USA 2002; 99:14386-14391. (Pubitemid 35257681)
35. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol 1990; 66:203-206. (Pubitemid 20235730)
36. Rebolledo MA, Krogstad P, Chen F, Shannon KM, Klitzner TS. Infection of human fetal cardiac myocytes by a human immunodeficiencyvirus-1-derived vector. CircRes 1998; 83:738-742. (Pubitemid 28462788)
37. BarbaroG,Di Lorenzo G, SoldiniM,GiancasproG,Grisorio B, Pellicelli A, et al. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation 1999; 100:933-939. (Pubitemid 29407173)
38. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004; 95:1140-1153. (Pubitemid 39648205)
39. Yunis NA, Stone VE. Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:145-154.
40. Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS 2003; 17 (Suppl 1):S12-S20. (Pubitemid 36667776)
41. Barbaro G, Lipshultz SE. Pathogenesis of HIV-associated cardiomyopathy. Ann N Y Acad Sci 2001; 946:57-81. (Pubitemid 33127209)
42. Berzingi C, Chen F, Finkel MS. p38 MAP kinase inhibitor prevents diastolic dysfunction in rats following HIV gp120 injection in vivo. Cardiovasc Toxicol 2009; 9:142-150.
43. Kan H, Xie Z, Finkel MS. iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes. J Mol Cell Cardiol 2006; 40:131-137. (Pubitemid 43012124)
44. Kan H, Xie Z, Finkel MS. p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes. Am J Physiol Cell Physiol 2004; 286:C1-C7. (Pubitemid 38055807)
45. Kan H, Xie Z, Finkel MS. HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NFkappaB activation. Am J Physiol Heart Circ Physiol 2000; 279:H3138-H3143. (Pubitemid 32005906)
46. Yuan Y, Kan H, Fang Q, Chen F, Finkel MS. CXCR4 receptor antagonist blocks cardiac myocyte p38 MAP kinase phosphorylation by HIV gp120. Cardiovasc Toxicol 2008; 8:173-180.
47. Pyo RT, Sui J, Dhume A, Palomeque J, Blaxall BC, Diaz G, et al. CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 2006; 41:834-844. (Pubitemid 44635574)
48. Monsuez JJ, Escaut L, Teicher E, Charniot JC, Vittecoq D. Cytokines in HIV-associated cardiomyopathy. Int J Cardiol 2007; 120:150-157. (Pubitemid 47049664)
49. Yearley JH, Mansfield KG, Carville AA, Sokos GG, Xia D, Pearson CB, et al. Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalpha. AIDS 2008; 22:585-594. (Pubitemid 351640591)
50. Mankowski JL, Clements JE, Zink MC. Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J Infect Dis 2002; 186 (Suppl 2):S199-S208. (Pubitemid 35370482)
51. Zink MC, Laast VA, Helke KL, Brice AK, Barber SA, Clements JE, et al. From mice to macaques: animal models of HIV nervous system disease. Curr HIV Res 2006; 4:293-305. (Pubitemid 44027719)
52. Kim WK, Alvarez X, Fisher J, Bronfin B, Westmoreland S, McLaurin J, et al. CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol 2006; 168:822-834. (Pubitemid 43327735)
53. Yearley JH, Pearson C, Shannon RP, Mansfield KG. Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease. AIDS Res Hum Retroviruses 2007; 23:515-524. (Pubitemid 46700884)